Peptides derived from apoA1 had previously been reported to inhibit HSV1 and HIV infection in vitro [11,20,21], and although we detected antiviral activity in the consensus domain peptide 18A previously found to be active, we did not obtain evidence of antibacterial activity for this peptide. Here, APOA1 is linked to HIV infectious disease.